Last reviewed · How we verify
NCT06247904: NIBS-SCI1
NIBS Therapy in Subacute Spinal Cord Injury
NA trial testing Active rTMS in Traumatic Spinal Cord Injury in 20 participants. Enrolling by invitation.
31 December 2025
Quick facts
| Lead sponsor | Albert Einstein Healthcare Network |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 9 April 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Active rTMS
- sham rTMS
Conditions studied
- Traumatic Spinal Cord Injury — all drugs for Traumatic Spinal Cord Injury →
- Tetraplegia/Tetraparesis — all drugs for Tetraplegia/Tetraparesis →
Sponsor
Albert Einstein Healthcare Network
Who can join
Adults 18 to 80, any sex, with Traumatic Spinal Cord Injury or Tetraplegia/Tetraparesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
No accepted clinical therapies exist for repair of motor pathways following spinal cord injury (SCI) in humans, leaving permanent disability and devastating personal and socioeconomic cost. A robust neural repair strategy has been demonstrated in preclinical studies, that is ready for translation to recovery of hand and arm function in human SCI, comprising daily transcranial magnetic stimulation treatment at the inpatient rehabilitation facility. This study will establish clinical effect size of the intervention, as well as safety and feasibility necessary for a subsequent controlled efficacy trial and inform preclinical studies for dosing optimization.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Repetitive transcranial magnetic stimulation for enhancing motor function after spinal cord injury: a narrative review.
Benavides F, Shine MG, Stefanovic F, Chen R, et al · · 2025 · cited 1× · PMID 40672464 · DOI 10.3389/fneur.2025.1587060
Verify or expand the search:
- PubMed search for NCT06247904
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Active rTMS
Trials testing the same drug.
- NCT07113990 — Electroacupuncture and rTMS for Post-Stroke Motor Recovery · NA · recruiting
- NCT06999772 — Combining Brain Stimulation and Physiotherapy for the Management of Chronic Low Back Pain · NA · recruiting
- NCT06961916 — Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) · NA · recruiting
- NCT06956300 — TMS for Cognitive Decline in Aging and Preclinical AD · NA · recruiting
- NCT06670820 — iTBS in MCI and Mild AD · NA · not yet recruiting
Other recruiting trials for Traumatic Spinal Cord Injury
Currently open trials in the same condition.
- NCT06463418 — Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP) · NA · recruiting
- NCT06520020 — Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal · NA · recruiting
- NCT05869968 — SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI · active not recruiting
- NCT06000592 — Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI · NA · recruiting
Other Albert Einstein Healthcare Network trials
Trials by the same sponsor.
- NCT07044323 — Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment · NA · recruiting
- NCT06028334 — GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI · NA · recruiting
- NCT04610346 — Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program · NA · completed
- NCT05687994 — Speech Entrainment Treatment for People With Aphasia · NA · completed
- NCT05351255 — Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06247904 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Albert Einstein Healthcare Network
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06247904.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing